- List
- By Topic
- On Map
- Search Details

migraine | Recruiting, Not yet recruiting, Available Studies | ( Map: Connecticut, United States )
Need help? See RSS Feeds
Choose a feed type:

migraine | Recruiting, Not yet recruiting, Available Studies | ( Map: Connecticut, United States ) (10 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03472378 | Recruiting | Can DFN-15 Terminate Migraine With Allodynia? |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
100 | All | 18 Years to 64 Years (Adult) | NCT03472378 | HHC-2017-0224 | April 1, 2018 | August 1, 2018 | September 1, 2018 | March 21, 2018 | March 23, 2018 |
|
|||
2 | NCT03341689 | Recruiting | Psilocybin for the Treatment of Migraine Headache |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
24 | All | 21 Years to 65 Years (Adult, Older Adult) | NCT03341689 | 1607018057.A | November 1, 2017 | November 1, 2019 | March 1, 2020 | November 14, 2017 | February 4, 2019 |
|
|||
3 | NCT03066544 | Recruiting | Status Migrainosus - Differentiating Between Responders and Non-responders |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT03066544 | HHC-2016-0221 | November 30, 2016 | December 31, 2019 | June 30, 2020 | February 28, 2017 | August 31, 2018 |
|
|||
4 | NCT03337620 | Recruiting | Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
180 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03337620 | 16-001TI | September 20, 2017 | January 1, 2019 | June 1, 2019 | November 9, 2017 | March 5, 2018 |
|
|||
5 | NCT03338920 | Recruiting | Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
420 | All | 12 Years to 17 Years (Child) | NCT03338920 | 17-AVP-825-301 | November 2, 2017 | November 2019 | November 2019 | November 9, 2017 | February 8, 2019 |
|
|||
6 | NCT03777059 | Recruiting | To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
872 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03777059 | 3101-301-002 | December 14, 2018 | February 5, 2020 | February 5, 2020 | December 17, 2018 | January 25, 2019 |
|
|||
7 | NCT03732638 | Recruiting | Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults |
|
|
Interventional |
Phase 2 Phase 3 |
|
Industry |
|
|
1200 | All | 18 Years and older (Adult, Older Adult) | NCT03732638 | BHV3000-305 | November 14, 2018 | September 30, 2019 | February 15, 2020 | November 6, 2018 | January 9, 2019 |
|
|||
8 | NCT03488563 | Recruiting | Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
303 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03488563 | MGB244-001 | March 30, 2018 | February 20, 2019 | February 20, 2019 | April 5, 2018 | December 11, 2018 |
|
|||
9 | NCT03275922 | Recruiting | Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
426 | All | 6 Years to 11 Years (Child) | NCT03275922 | IPX229-B16-01 | December 4, 2017 | April 2020 | May 2020 | September 8, 2017 | February 15, 2019 |
|
|||
10 | NCT01431326 | Recruiting | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care |
|
|
Observational |
|
Other / NIH / Industry |
|
|
10000 | All | up to 21 Years (Child, Adult) | NCT01431326 | Pro00029638 IND 113645 IND 114369 IND 114531 IND 118358 HHSN20100006 HHSN27500020 HHSN27500027 HHSN27500043 HHSN27500049 |
PTN_POPS | November 2011 | February 2020 | February 2020 | September 9, 2011 | April 4, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.